Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience

导出原文传递

翻译打印收藏纠错

作者： Kuo, Christopher ^[1] ; Kent, Paul M. ^[2] ; Logan, Antonio D. ^[3] ; Tamulonis, Karen B. ^[4] ; Dalton, Kristen L. ^[5] ; Batus, Marta ; Fernandez, Karen ; Mcfall, Rebecca E.

作者单位： Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA ^[1] Advocate Christ Med Ctr, Dept Pediat, Div Hematol Oncol, Oak Lawn, IL USA ^[2] Rush Univ, Med Ctr, Dept Pediat, Div Pediat Hematol Oncol, Chicago, IL 60612 USA ^[3] Rush Univ, Med Ctr, Dept Internal Med, Div Med Oncol, Chicago, IL 60612 USA ^[4] Univ Illinois, Coll Med, Dept Pediat, Div Hematol Oncol, Peoria, IL 61656 USA ^[5]

关键词 bevacizumab docetaxel Ewing sarcoma gemcitabine osteosarcoma soft tissue sarcomas

发布时间 2017-10-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交